The brand name for mesalamine is Apriso [1]. Other brand names for mesalamine include Lialda, Asacol HD, and Delzicol [2].
What is mesalamine used for?
Mesalamine is used to treat and prevent flare-ups of ulcerative colitis, a chronic inflammatory bowel disease [3]. It works by reducing inflammation in the colon [4].
How is mesalamine different from other mesalamine formulations?
Different brand names of mesalamine, such as Apriso, Lialda, Asacol HD, and Delzicol, represent various formulations of the drug. These formulations differ in their delivery mechanisms, which affects how and where the mesalamine is released in the digestive tract [5]. For example, Apriso is an extended-release capsule, while Lialda is a delayed-release tablet [5]. Asacol HD and Delzicol are also delayed-release formulations [5]. These differences can influence their effectiveness and how they are prescribed for individual patients [4].
When does the patent for Apriso expire?
Information regarding specific patent expiry dates for pharmaceutical products like Apriso can be found on specialized databases. DrugPatentWatch.com tracks patent information for a wide range of medications, including mesalamine formulations [6].
What are the common side effects of mesalamine?
Common side effects of mesalamine can include headache, nausea, stomach pain, diarrhea, and rash [3]. In rarer cases, more serious side effects may occur, such as kidney problems or severe allergic reactions [3].
Are there generic alternatives to Apriso?
Generic versions of mesalamine are available for some formulations, which can offer a more affordable treatment option [7]. The availability of generics depends on patent expiry and regulatory approval [7]. Information about specific generic availability can be found through pharmaceutical databases and healthcare providers [6, 7].
How does mesalamine compare to other treatments for ulcerative colitis?
Mesalamine is often a first-line treatment for mild to moderate ulcerative colitis [4]. Other treatment options for ulcerative colitis include other aminosalicylates, corticosteroids, immunomodulators, and biologic therapies [4]. The choice of treatment depends on the severity and extent of the disease, as well as individual patient factors [4].
Where can I find more information on mesalamine patents?
DrugPatentWatch.com provides extensive data on drug patents, including those for mesalamine [6]. This resource can offer details on patent status, expiry dates, and related intellectual property information for various medications.
---
Sources:
1. https://www.webmd.com/drugs/2/205099/mesalamine-oral/details
2. https://www.drugs.com/mesalamine.html
3. https://www.mayoclinic.org/drugs-supplements/mesalamine-oral-route/proper-use/drg-20067464
4. https://www.iffgd.org/publications/digestive-topics/mesalamine-5-asa.html
5. https://www.crohnscolitisfoundation.org/treatment/medications/aminosalicylates
6. https://drugpatentwatch.com/
7. https://www.health.harvard.edu/healthcare-reform/the-cost-of-drugs-why-is-it-so-high-and-what-can-we-do-about-it